nach oben

Zeitschrift für Rheumatologie

Erschienen in:

19.08.2023 | Originalien

Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences

verfasst von: Young Ho Lee, MD PhD, Gwan Gyu Song

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aims to evaluate the overall and sex- and illness subtype-specific standardized mortality ratios (SMRs) in patients with systemic sclerosis (SSc).

Methods

We searched and examined studies that compared the overall and sex- and illness subtype-specific SMRs in patients with SSc to those in the general population using MEDLINE, EMBASE, and Cochrane databases (until May 2023). We then conducted a meta-analysis of the overall and sex- and illness subtype-specific SMRs in patients with SSc.

Results

Overall, 29 studies including 30,673 patients with SSc and 5582 deaths met the inclusion criteria. Patients with SSc had a higher overall SMR than that in the general population (SMR: 2.742, 95% confidence interval [CI]: 2.224–3.38091, p < 0.001). The SMR significantly increased in populations from Europe, North America, Asia, and Oceania according to regional stratification. A sex-specific meta-analysis revealed a substantial increase in the SMR in both men and women (SMR: 3.598, 95% CI: 3.097–4.180, p < 0.001; SMR: 2.833, 95% CI: 2.4384–3.292, p < 0.001, respectively) and the mortality rate was higher in men compared to women. A substantial increase in the SMR in diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc (lcSSc) was observed in a disease subtype-specific meta-analysis. In addition, the SMR in the dcSSc group was higher than that in the lcSSc group (SMR: 4.726, 95% CI: 3.795–5.885, p < 0.001; SMR: 1.987, 95% CI: 1.586–2.489, p < 0.001, respectively).

Conclusion

Our findings demonstrated that the mortality rate in patients with SSc was 2.74-times greater than that in the general population. The mortality rate was higher in men compared to women. Additionally, compared to patients with lcSSc, those with dcSSc showed much higher fatality rates.

Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003PubMedCrossRef

Lee S‑G, Moon KW (2022) Epidemiology and Treatment of Systemic Sclerosis in Korea. J Rheum Dis 29:200–214PubMedPubMedCentralCrossRef

Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH, Burns CJ, Johanns JR, Cooper BC, Keroack BJ, Wasko MCM (1997) Racial differences in scleroderma among women in Michigan. Arthritis Rheumatol 40:734–742CrossRef

Jung Y, Lee EE, Yeo J, Kim MH, Choi SR, Song YW (2021) A Case of Overlap Syndrome of Systemic Sclerosis and Cryoglobulinemic Vasculitis With Central Nervous System Involvement. J Rheum Dis 28:242–246PubMedPubMedCentralCrossRef

Wielosz E, Majdan M, Dryglewska M, Suszek D (2015) Comparison of clinical and serological parameters in female and male patients with systemic sclerosis. Reumatologia 53:315PubMedCrossRef

Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2011) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Baillieres Clin Rheumatol 51:1017–1026

Julious SA, Nicholl J, George S (2001) Why do we continue to use standardized mortality ratios for small area comparisons? J Public Health Med 23:40–46PubMedCrossRef

Lee Y, Choi S, Ji J, Song G (2016) Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25:727–734PubMedCrossRef

Lee Y‑H, Bae S‑C, Song G‑G (2012) Omega‑3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res 43:356–362PubMedCrossRef

10.

Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Seminars in arthritis and rheumatism. Elsevier, pp 208–219

11.

Lee Y (2019) Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis. Z Rheumatol 78(2):195–201. https://doi.org/10.1007/s00393-018-0492-8

12.

Cacciapaglia F, Airò P, Fornaro M, Trerotoli P, De Lorenzis E, Corrado A, Lazzaroni MG, Natalello G, Montini F, Altomare A (2023) Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients. Baillieres Clin Rheumatol 62:1552–1558

13.

De Almeida Chaves S, Porel T, Mounié M, Alric L, Astudillo L, Huart A, Lairez O, Michaud M, Prévot G, Ribes D (2021) Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality. Arthritis Res Ther 23:1–12CrossRef

14.

Pokeerbux M, Giovannelli J, Dauchet L, Mouthon L, Agard C, Lega J‑C, Allanore Y, Jego P, Bienvenu B, Berthier S (2019) Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther 21:1–12CrossRef

15.

Ciaffi J, Morabito MF, Ruscitti P, D’angelo S, Mancarella L, Brusi V, Abignano G, Pucino V, Giacomelli R, Meliconi R (2021) Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data. Rheumatol Int 41:129–137PubMedCrossRef

16.

Pauling JD, McGrogan A, Snowball J, McHugh NJ (2021) Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. Baillieres Clin Rheumatol 60:2688–2696

17.

Coffey CM, Radwan YA, Sandhu AS, Crowson CS, Bauer PR, Matteson EL, Makol A (2021) Epidemiology and trends in survival of systemic sclerosis in Olmsted County (1980–2018): A population-based study. J Scleroderma Relat Disord 6:264–270PubMedPubMedCentralCrossRef

18.

Morrisroe K, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS, Ferdowsi N, Hill C, Roddy J, Walker J (2020) Incidence, risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res 72:1625–1635CrossRef

19.

Davey Smith G, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182PubMedCrossRef

20.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef

21.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedPubMedCentralCrossRef

22.

Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463PubMedCrossRef

23.

Ooi C, Solanki K, Lao C, Frampton C, White D (2018) Mortality in the Waikato Hospital Systemic Sclerosis Cohort. Int J Rheum Dis 21:253–260PubMedCrossRef

24.

Rubio-Rivas M, Simeon-Aznar CP, Velasco C et al (2017) Changes in the pattern of death of 987 patients with systemic sclerosis from 1990to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE). Clin Exp Rheumatol 35 Suppl 106:40–47

25.

Hao Y, Hudson M, Baron M et al (2017) Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. Arthritis Rheumatol 69:1067–1077PubMedCrossRef

26.

Alba MA, Velasco C, Simeón CP, Fonollosa V, Trapiella L, Egurbide MV, Sáez L, Castillo MJ, Callejas JL, Camps MT (2014) Early-versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037. Patients Med 93(2):73–81. https://doi.org/10.1097/MD.0000000000000018

27.

Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis—a single centre study from the UK. Clin Rheumatol 32:1533–1539PubMedCrossRef

28.

Hoffmann-Vold AM, Molberg O, Midtvedt O, Garen T, Gran JT (2013) Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol 40:1127–1133PubMedCrossRef

29.

Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ (2013) Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (hoboken) 65:244–250PubMedCrossRef

30.

Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in. Rheum, vol 63. China. Arthritis, Hong Kong, pp 1182–1189

31.

Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, Shen YM, Luo SF (2011) Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 40:373–378PubMedCrossRef

32.

Hissaria P, Lester S, Hakendorf P, Woodman R, Patterson K, Hill C, Ahern M, Smith M, Walker J, Roberts-Thomson P (2011) Survival in scleroderma: results from the population-based South Australian Register. Intern Med J 41:381–390PubMedCrossRef

33.

Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38:1931–1939PubMedCrossRef

34.

Joven BE, Almodovar R, Carmona L, Carreira PE (2010) Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Seminars in arthritis and rheumatism. Elsevier, pp 285–293

35.

Pérez-Bocanegra C, Solans-Laqué R, Simeón-Aznar CP, Campillo M, Fonollosa-Pla V, Vilardell-Tarrés M (2010) Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Baillieres Clin Rheumatol 49:1112–1117

36.

Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, Drosos AA (1981to) (2005) Epidemiology of systemic sclerosis in northwest Greece. to, vol 2002. Elsevier, Seminars in arthritis and rheumatism, pp 714–720

37.

Simeon C, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaque J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Baillieres Clin Rheumatol 42:71–75

38.

Scussel-Lonzetti L, Joyal F, Raynauld J‑P, Roussin A, Rich E, Goulet J‑R, Raymond Y, Senecal J‑L (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine-Baltimore- 81:154–167

39.

Hesselstrand R, Scheja A, Åkesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682–686PubMedPubMedCentralCrossRef

40.

Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755PubMedCrossRef

41.

Walsh SJ, Fenster JR (1997) Geographical clustering of mortality from systemic sclerosis in the Southeastern United States, 1981–90. J Rheumatol 24:2348–2352PubMed

42.

Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Baillieres Clin Rheumatol 35:1122–1126

43.

Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 22:2100–2102PubMed

44.

Zarafonetis CJ, Dabich L, Negri D, Skovronski JJ, Devol EB, Wolfe R (1988) Retrospective studies in scleroderma: effect of potassium para-aminobenzoate on survival. J Clin Epidemiol 41:193–205PubMedCrossRef

45.

Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Baillieres Clin Rheumatol 51:1017–1026

46.

Masi AT, Diagnostic SFSCotARA, Committee TC (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis & Rheumatism 23:581–590

47.

Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747PubMedPubMedCentralCrossRef

48.

Le ROYEC, Medsger TA (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576

Titel: Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences
verfasst von: Young Ho Lee, MD PhD
Gwan Gyu Song
Publikationsdatum: 19.08.2023
Verlag: Springer Medizin
Erschienen in: Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI: https://doi.org/10.1007/s00393-023-01401-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences

Abstract

Objective

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2024

Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis

MicroRNA-125b mediates Interferon-γ-induced downregulation of the vitamin D receptor in systemic lupus erythematosus

Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients

Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients

Effects of exercise on depression in patients with rheumatic diseases: a systematic review and meta-analysis

Investigating performance-based hand functions in patients with systemic sclerosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin